In breast cancer bone metastasis, the release of osteolytic factors from breast cancer cells exacerbates cancer cell-mediated bone loss by increasing the RANKL/OPG ratio in osteoblastic cells and consequently causing osteoclast-mediated bone resorption [39]. This evidence concerns the gene TNFRSF11B and breast carcinoma.